Core Laboratories reported a 5% sequential revenue increase in Q2 2025, driven by improved demand for lab services and enhanced operating margins across its segments.

• Revenue reached $130.2 million, with a 7% rise in Reservoir Description and a 3% increase in Production Enhancement compared to Q1.
• Operating margins improved to 13% in Reservoir Description and 9% in Production Enhancement, reflecting strong demand for high-margin services.
• Core continued its commitment to shareholder returns, repurchasing over 237,000 shares and reducing net debt by more than $9 million, achieving a leverage ratio of 1.27, the lowest in 8 years.
• The company remains focused on innovation and geographic expansion while adhering to its financial tenets, including maximizing free cash flow and return on invested capital.